Insiders · BMY

Deepak Bhatt

Director at Bristol Myers Squibb Co (BMY) since June 2022

Deepak Bhatt has filed 16 insider reports with the SEC since June 2022, as director at Bristol Myers Squibb Co (BMY). The latest filing, on February 3, 2026, reports grant or award at Bristol Myers Squibb Co (BMY).

Filings
16
Companies
1
Bought on market
None
Sold on market
None

Companies where Deepak Bhatt is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Bristol Myers Squibb Co logo
BMY
Bristol Myers Squibb Co
Directorsince June 2022$58.80Feb 3, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Deepak Bhatt with

Other insiders at the same companies

Questions about Deepak Bhatt

What is Deepak Bhatt's role at Bristol Myers Squibb Co?
Deepak Bhatt reports to the SEC as director at Bristol Myers Squibb Co (BMY), according to the latest filing on February 3, 2026.
Has Deepak Bhatt bought or sold stock recently?
No open-market purchases or sales by Deepak Bhatt are on file. The filings report grant or award.
How do I get alerts when Deepak Bhatt files?
Follow Deepak Bhatt on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Deepak Bhatt (SEC CIK 0001934074). Totals count each trade once, skipping amendments whose original is on file, from Jun 16, 2022 on. View on SEC EDGAR · Get this as JSON